NCT06212830View on ClinicalTrials.gov

Pain Relief After Corneal Collagen Cross-Linking

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

August 31, 2025

Conditions
Provide Evidence-based Recommendations for Clinicians to Optimize Pain Control After CXL
Interventions
DRUG

Gabapentin

Gabapentin 200 mg twice a day, starting from the night prior to the procedure and continue 48 hours after

DRUG

Targin

Targin 5 mg twice a day after the procedure for 48 hours

DRUG

NSAID

Nurofen (NSAID) 200 mg twice a day after the procedure for 48 hours

DRUG

Paracetamol

Paracetamol 500 mg every 4 hours during waking hours after the procedure for 48 hours

Trial Locations (1)

7033001

Shamir Medical Center (Assaf Harofeh), Be’er Ya‘aqov

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT06212830 - Pain Relief After Corneal Collagen Cross-Linking | Biotech Hunter | Biotech Hunter